Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.
Bartelds GM, Krieckaert CL, Nurmohamed MT, van Schouwenburg PA, Lems WF, Twisk JW, Dijkmans BA, Aarden L, Wolbink GJ
Jan van Breemen Research Institute, Amsterdam, The Netherlands.
Published 13 April 2011 in JAMA, 305(14): 1460-8.
Full-text of this article is available online (may require subscription).
Articles on Rheumatoid Arthritis published 13 April 2011:
Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. JAMA, 305(14): 1460-8.
[Abstract] [Full-text]
Articles on Rheumatoid Arthritis published 22 March 2011:
The sparkle of the eye: the impact of ocular surface wetness on corneal light reflection. Am J Ophthalmol, 151(4): 691-696.e1.
[Abstract] [Full-text]
Articles on Rheumatoid Arthritis published 4 March 2011:
Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis Register. Ann Rheum Dis, 70(4): 642-5.
[Abstract] [Full-text]
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis, 70(4): 583-9.
[Abstract] [Full-text]
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis, 70(4): 611-5.
[Abstract] [Full-text]
Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis, 70(4): 660-7.
[Abstract] [Full-text]
Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort. Ann Rheum Dis, 70(4): 634-7.
[Abstract] [Full-text]
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis, 70(4): 624-9.
[Abstract] [Full-text]
© 2004-2011 Rheumatoid Arthritis Research Today. All Rights Reserved.
| 
